No suprises in store from GlaxoSmithKline, say analysts

Analysts are expecting few surprises when GlaxoSmithKline reveals its first quarter results tomorrow.

No suprises in store from GlaxoSmithKline, say analysts

Analysts are expecting few surprises when GlaxoSmithKline reveals its first quarter results tomorrow.

They said teething problems arising from the merger of Glaxo Wellcome and SmithKline Beecham will have been ironed out, creating a positive performance.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited